新手上路。
New Kid on the Block.
机构信息
Institute of Molecular Medicine and Cell Research, Faculty of Medicine, Albert-Ludwigs-University Freiburg, and German Cancer Consortium (DKTK), Partner site Freiburg, Freiburg, Germany.
出版信息
Theranostics. 2017 Jul 30;7(11):2965-2967. doi: 10.7150/thno.21603. eCollection 2017.
Abstract
Cysteine cathepsins are a group of proteases involved in many physiological and pathological processes. Yet, the selective detection and inhibition of individual cathepsins is still challenging. This editorial is discussing the context of a recent work introducing a designed ankyrin repeat protein (DARPin) as novel approach for selective targeting of the protease cathepsin B.
摘要
半胱氨酸组织蛋白酶属于一大类蛋白酶，参与多种生理和病理过程。然而，对于特定组织蛋白酶的选择性检测和抑制仍然具有挑战性。这篇社论讨论了最近一项工作的背景，该工作介绍了一种设计的锚蛋白重复蛋白（DARPin），作为选择性靶向蛋白酶组织蛋白酶 B 的新方法。
相似文献
1
New Kid on the Block.新手上路。
Theranostics. 2017 Jul 30;7(11):2965-2967. doi: 10.7150/thno.21603. eCollection 2017.
2
Non-invasive imaging of tumour-associated cathepsin B by a highly selective inhibitory DARPin.利用高选择性抑制性抗肌动蛋白重复结构域蛋白对肿瘤相关组织蛋白酶B进行无创成像
Theranostics. 2017 Jul 8;7(11):2806-2821. doi: 10.7150/thno.19081. eCollection 2017.
3
Distinct properties of prohormone thiol protease (PTP) compared to cathepsins B, L, and H: evidence for PTP as a novel cysteine protease.与组织蛋白酶B、L和H相比，激素原硫醇蛋白酶（PTP）的独特性质：PTP作为一种新型半胱氨酸蛋白酶的证据。
Arch Biochem Biophys. 1994 Oct;314(1):171-7. doi: 10.1006/abbi.1994.1426.
4
Expression and regulation of three lysosomal cysteine protease activities during growth of a differentiating L6 rat myoblast cell line and its nonfusing variant.在分化的L6大鼠成肌细胞系及其非融合变体生长过程中三种溶酶体半胱氨酸蛋白酶活性的表达与调控
Biochem Cell Biol. 1994 Jul-Aug;72(7-8):267-74. doi: 10.1139/o94-038.
5
Cysteine cathepsins are not critical for TRAIL- and CD95-induced apoptosis in several human cancer cell lines.半胱氨酸组织蛋白酶对于几种人癌细胞系中 TRAIL 和 CD95 诱导的细胞凋亡不是必需的。
Biol Chem. 2012 Dec;393(12):1417-31. doi: 10.1515/hsz-2012-0213.
6
A selective cysteine protease inhibitor is non-toxic and cerebroprotective in rats undergoing transient middle cerebral artery ischemia.一种选择性半胱氨酸蛋白酶抑制剂对短暂性大脑中动脉缺血的大鼠无毒且具有脑保护作用。
Brain Res. 2001 May 18;901(1-2):94-101. doi: 10.1016/s0006-8993(01)02289-2.
7
Quinazoline derivatives as cathepsins B, H and L inhibitors and cell proliferating agents.喹唑啉衍生物作为组织蛋白酶B、H和L抑制剂及细胞增殖剂。
Int J Biol Macromol. 2017 Jan;94(Pt A):719-727. doi: 10.1016/j.ijbiomac.2016.10.001. Epub 2016 Oct 22.
8
Identification and discrimination of extracellularly active cathepsins B and L in high-invasive melanoma cells.高侵袭性黑色素瘤细胞中细胞外活性组织蛋白酶B和L的鉴定与区分
Anal Biochem. 2006 Jun 1;353(1):57-62. doi: 10.1016/j.ab.2006.01.037. Epub 2006 Feb 9.
9
Cathepsin B but not cathepsins L or S contributes to the pathogenesis of Unverricht-Lundborg progressive myoclonus epilepsy (EPM1).组织蛋白酶B而非组织蛋白酶L或S参与了翁韦里希特-伦德伯格进行性肌阵挛癫痫（EPM1）的发病机制。
J Neurobiol. 2003 Sep 15;56(4):315-27. doi: 10.1002/neu.10253.
10
Reduced cystatin B activity correlates with enhanced cathepsin activity in progressive myoclonus epilepsy.在进行性肌阵挛性癫痫中，胱抑素B活性降低与组织蛋白酶活性增强相关。
Ann Med. 2002;34(5):380-5. doi: 10.1080/078538902320772124.
引用本文的文献
1
Identification and targeting of metastatic biomarkers for hepatocellular carcinoma therapeutics using small molecules library of curcumin analogues.利用姜黄素类似物小分子文库鉴定和靶向肝细胞癌治疗的转移生物标志物
Mol Divers. 2025 Feb;29(1):503-517. doi: 10.1007/s11030-024-10871-3. Epub 2024 Apr 30.
2
Cathepsins in the Pathophysiology of Mucopolysaccharidoses: New Perspectives for Therapy.黏多糖贮积症发病机制中的组织蛋白酶：治疗的新视角。
Cells. 2020 Apr 15;9(4):979. doi: 10.3390/cells9040979.
本文引用的文献
1
Non-invasive imaging of tumour-associated cathepsin B by a highly selective inhibitory DARPin.利用高选择性抑制性抗肌动蛋白重复结构域蛋白对肿瘤相关组织蛋白酶B进行无创成像
Theranostics. 2017 Jul 8;7(11):2806-2821. doi: 10.7150/thno.19081. eCollection 2017.
2
Inherited diseases caused by mutations in cathepsin protease genes.由组织蛋白酶蛋白酶基因突变引起的遗传性疾病。
FEBS J. 2017 May;284(10):1437-1454. doi: 10.1111/febs.13980. Epub 2017 Jan 12.
3
A Bright Future for Precision Medicine: Advances in Fluorescent Chemical Probe Design and Their Clinical Application.精准医学的光明未来：荧光化学探针设计的进展及其临床应用。
Cell Chem Biol. 2016 Jan 21;23(1):122-136. doi: 10.1016/j.chembiol.2015.12.003.
4
Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response.半胱氨酸组织蛋白酶蛋白酶：癌症进展和治疗反应的调节剂。
Nat Rev Cancer. 2015 Dec;15(12):712-29. doi: 10.1038/nrc4027.
5
Designed ankyrin repeat proteins (DARPins): binding proteins for research, diagnostics, and therapy.设计锚蛋白重复蛋白（DARPins）：用于研究、诊断和治疗的结合蛋白。
Annu Rev Pharmacol Toxicol. 2015;55:489-511. doi: 10.1146/annurev-pharmtox-010611-134654.
6
Specialized roles for cysteine cathepsins in health and disease.半胱氨酸蛋白酶在健康和疾病中的特异性作用。
J Clin Invest. 2010 Oct;120(10):3421-31. doi: 10.1172/JCI42918. Epub 2010 Oct 1.
7
Regulation of cathepsin B activity by 2A2 monoclonal antibody.2A2单克隆抗体对组织蛋白酶B活性的调节
FEBS J. 2009 Sep;276(17):4739-51. doi: 10.1111/j.1742-4658.2009.07171.x. Epub 2009 Jul 27.
Zotero 插件